Pembrolizumab Versus Docetaxel For Previously Treated, PD-L1-positive, Advanced Non-Small-Cell Lung Cancer (KEYNOTE-010): A Randomised Controlled Trial
Role in the Field
Neutralin Health Sciences and Innovation
Neutralin Biomedical Engineering
Neutralin Cancer Research and Treatment
Neutralin Cancer Immunotherapy Advances
Abstract
Citations
4,532
Year
2016
PageRank
4.6 / 10
Relative influence (log-scaled)